Sarcoidosis in America

Analysis based on health care use

Robert P. Baughman, Shelli Field, Ulrich Costabel, Ronald Crystal, Daniel A. Culver, Marjolein Drent, Marc A. Judson, Gerhard Wolff

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Rationale: There have been no recent comprehensive studies of the epidemiology of sarcoidosis in the United States. Changes in health care use have made available access to data on large numbers of patients with sarcoidosis. Objectives: To use a U.S. national health care database to gather data on patients with sarcoidosis identified over a 3-year period who were 18 years of age and older, and to determine health care costs for these patients. Methods: The Optum health care database was queried for a 3-year period (2010-2013). This database includes approximately 15% of U.S. residents. The incidence rate of sarcoidosis was calculated for new cases identified in each year. Calculation of prevalence was based on any patient with sarcoidosis seen during the year. Incidence and prevalence rates are reported per 100,000 patients. Measurements and Main Results: A total of 29,372 adult patients with sarcoidosis were identified. Of these, 14,700 (55%) were over 55 years of age at the time of diagnosis. The incidence and prevalence rates were higher for African Americans (17.8 and 141.4 per 100,000, respectively) than for white individuals (8.1 and 49.8), Hispanics (4.3 and 21.7), or Asians (3.2 and 18.9). Women were two times more likely to have sarcoidosis, with the highest prevalence for sarcoidosis noted in African American women (178.5). Overall, the yearly health care cost reported for patients with sarcoidosis was low, with a median of $18,663 per year. However, the yearly cost for the top 5% was $93,201. Conclusions: Forpatients 18 years of age and older enrolled in a U.S. national administrative database, sarcoidosis was more common among African Americans, but it was reported for all four of the major ethnic groups studied. While health care costs were relatively small for most patients, the cost of care for some patients was considerable.

Original languageEnglish
Pages (from-to)1244-1252
Number of pages9
JournalAnnals of the American Thoracic Society
Volume13
Issue number8
DOIs
Publication statusPublished - 1 Jan 2016
Externally publishedYes

Fingerprint

Sarcoidosis
Delivery of Health Care
African Americans
Databases
Health Care Costs
Incidence
Costs and Cost Analysis
Hispanic Americans
Ethnic Groups
Patient Care
Epidemiology

Keywords

  • Epidemiology
  • Health care use
  • Race
  • Sarcoidosis
  • Sex

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Baughman, R. P., Field, S., Costabel, U., Crystal, R., Culver, D. A., Drent, M., ... Wolff, G. (2016). Sarcoidosis in America: Analysis based on health care use. Annals of the American Thoracic Society, 13(8), 1244-1252. https://doi.org/10.1513/AnnalsATS.201511-760OC

Sarcoidosis in America : Analysis based on health care use. / Baughman, Robert P.; Field, Shelli; Costabel, Ulrich; Crystal, Ronald; Culver, Daniel A.; Drent, Marjolein; Judson, Marc A.; Wolff, Gerhard.

In: Annals of the American Thoracic Society, Vol. 13, No. 8, 01.01.2016, p. 1244-1252.

Research output: Contribution to journalArticle

Baughman, RP, Field, S, Costabel, U, Crystal, R, Culver, DA, Drent, M, Judson, MA & Wolff, G 2016, 'Sarcoidosis in America: Analysis based on health care use', Annals of the American Thoracic Society, vol. 13, no. 8, pp. 1244-1252. https://doi.org/10.1513/AnnalsATS.201511-760OC
Baughman, Robert P. ; Field, Shelli ; Costabel, Ulrich ; Crystal, Ronald ; Culver, Daniel A. ; Drent, Marjolein ; Judson, Marc A. ; Wolff, Gerhard. / Sarcoidosis in America : Analysis based on health care use. In: Annals of the American Thoracic Society. 2016 ; Vol. 13, No. 8. pp. 1244-1252.
@article{999b9ac762bb441ab9937c8b7ad176e1,
title = "Sarcoidosis in America: Analysis based on health care use",
abstract = "Rationale: There have been no recent comprehensive studies of the epidemiology of sarcoidosis in the United States. Changes in health care use have made available access to data on large numbers of patients with sarcoidosis. Objectives: To use a U.S. national health care database to gather data on patients with sarcoidosis identified over a 3-year period who were 18 years of age and older, and to determine health care costs for these patients. Methods: The Optum health care database was queried for a 3-year period (2010-2013). This database includes approximately 15{\%} of U.S. residents. The incidence rate of sarcoidosis was calculated for new cases identified in each year. Calculation of prevalence was based on any patient with sarcoidosis seen during the year. Incidence and prevalence rates are reported per 100,000 patients. Measurements and Main Results: A total of 29,372 adult patients with sarcoidosis were identified. Of these, 14,700 (55{\%}) were over 55 years of age at the time of diagnosis. The incidence and prevalence rates were higher for African Americans (17.8 and 141.4 per 100,000, respectively) than for white individuals (8.1 and 49.8), Hispanics (4.3 and 21.7), or Asians (3.2 and 18.9). Women were two times more likely to have sarcoidosis, with the highest prevalence for sarcoidosis noted in African American women (178.5). Overall, the yearly health care cost reported for patients with sarcoidosis was low, with a median of $18,663 per year. However, the yearly cost for the top 5{\%} was $93,201. Conclusions: Forpatients 18 years of age and older enrolled in a U.S. national administrative database, sarcoidosis was more common among African Americans, but it was reported for all four of the major ethnic groups studied. While health care costs were relatively small for most patients, the cost of care for some patients was considerable.",
keywords = "Epidemiology, Health care use, Race, Sarcoidosis, Sex",
author = "Baughman, {Robert P.} and Shelli Field and Ulrich Costabel and Ronald Crystal and Culver, {Daniel A.} and Marjolein Drent and Judson, {Marc A.} and Gerhard Wolff",
year = "2016",
month = "1",
day = "1",
doi = "10.1513/AnnalsATS.201511-760OC",
language = "English",
volume = "13",
pages = "1244--1252",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "8",

}

TY - JOUR

T1 - Sarcoidosis in America

T2 - Analysis based on health care use

AU - Baughman, Robert P.

AU - Field, Shelli

AU - Costabel, Ulrich

AU - Crystal, Ronald

AU - Culver, Daniel A.

AU - Drent, Marjolein

AU - Judson, Marc A.

AU - Wolff, Gerhard

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Rationale: There have been no recent comprehensive studies of the epidemiology of sarcoidosis in the United States. Changes in health care use have made available access to data on large numbers of patients with sarcoidosis. Objectives: To use a U.S. national health care database to gather data on patients with sarcoidosis identified over a 3-year period who were 18 years of age and older, and to determine health care costs for these patients. Methods: The Optum health care database was queried for a 3-year period (2010-2013). This database includes approximately 15% of U.S. residents. The incidence rate of sarcoidosis was calculated for new cases identified in each year. Calculation of prevalence was based on any patient with sarcoidosis seen during the year. Incidence and prevalence rates are reported per 100,000 patients. Measurements and Main Results: A total of 29,372 adult patients with sarcoidosis were identified. Of these, 14,700 (55%) were over 55 years of age at the time of diagnosis. The incidence and prevalence rates were higher for African Americans (17.8 and 141.4 per 100,000, respectively) than for white individuals (8.1 and 49.8), Hispanics (4.3 and 21.7), or Asians (3.2 and 18.9). Women were two times more likely to have sarcoidosis, with the highest prevalence for sarcoidosis noted in African American women (178.5). Overall, the yearly health care cost reported for patients with sarcoidosis was low, with a median of $18,663 per year. However, the yearly cost for the top 5% was $93,201. Conclusions: Forpatients 18 years of age and older enrolled in a U.S. national administrative database, sarcoidosis was more common among African Americans, but it was reported for all four of the major ethnic groups studied. While health care costs were relatively small for most patients, the cost of care for some patients was considerable.

AB - Rationale: There have been no recent comprehensive studies of the epidemiology of sarcoidosis in the United States. Changes in health care use have made available access to data on large numbers of patients with sarcoidosis. Objectives: To use a U.S. national health care database to gather data on patients with sarcoidosis identified over a 3-year period who were 18 years of age and older, and to determine health care costs for these patients. Methods: The Optum health care database was queried for a 3-year period (2010-2013). This database includes approximately 15% of U.S. residents. The incidence rate of sarcoidosis was calculated for new cases identified in each year. Calculation of prevalence was based on any patient with sarcoidosis seen during the year. Incidence and prevalence rates are reported per 100,000 patients. Measurements and Main Results: A total of 29,372 adult patients with sarcoidosis were identified. Of these, 14,700 (55%) were over 55 years of age at the time of diagnosis. The incidence and prevalence rates were higher for African Americans (17.8 and 141.4 per 100,000, respectively) than for white individuals (8.1 and 49.8), Hispanics (4.3 and 21.7), or Asians (3.2 and 18.9). Women were two times more likely to have sarcoidosis, with the highest prevalence for sarcoidosis noted in African American women (178.5). Overall, the yearly health care cost reported for patients with sarcoidosis was low, with a median of $18,663 per year. However, the yearly cost for the top 5% was $93,201. Conclusions: Forpatients 18 years of age and older enrolled in a U.S. national administrative database, sarcoidosis was more common among African Americans, but it was reported for all four of the major ethnic groups studied. While health care costs were relatively small for most patients, the cost of care for some patients was considerable.

KW - Epidemiology

KW - Health care use

KW - Race

KW - Sarcoidosis

KW - Sex

UR - http://www.scopus.com/inward/record.url?scp=85012870966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012870966&partnerID=8YFLogxK

U2 - 10.1513/AnnalsATS.201511-760OC

DO - 10.1513/AnnalsATS.201511-760OC

M3 - Article

VL - 13

SP - 1244

EP - 1252

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 8

ER -